Nephron Pharmaceuticals Corporation is a private woman owned manufacturer of generic inhalation solutions. Nephron specializes in blow-fill-seal (BFS)
manufacturing, a technology that allows a vial of medication to be formed, filled and sealed in a continuous process without human intervention
in a sterile, enclosed area.
As an industry leader in product safety and quality, Nephron continuously pursues product enhancements, such as easy to identify vial shapes, embossed
lettering and color-coded packaging. In 2001, prior to FDA’s 2004 mandate, Nephron led the market in the development and release of individually
wrapped and bar-coded medication. Individually wrapped and bar-coded vials are a major patient safety feature and are now standard treatments in
the bedside safety practices of US hospitals.
Nephron has longstanding relationships with major drug wholesalers to distribute its products among retail pharmacies, mail order pharmacies, hospitals,
home care companies, and long term care facilities. Nephron has a dedicated sales force that covers all fifty states and Puerto Rico, and has additional
sales channels throughout South America, the Middle East, and Europe.
Nephron’s new state-of-the-art facility in West Columbia, SC is over 400,000 square feet and has room for growth. The company employs approximately
500 employees. Nephron is actively in search of additional partnerships with various pharmaceutical and biological companies throughout the world
and is enthusiastic about plans for future growth in respiratory, ophthalmic and injectable medications.